Avenna at NOAH Conference 2019

      

 

This is a recording of our presentation at this renown tech conference. Our CEO discusses the burden of chronic inflammatory diseases (CIDs) and limitations in CIDs diagnostic procedures. Additionally, this presentation explains how Avenna medical technology can reliably detect and predict future CIDs using molecular signals from blood samples

.